A pyrene-based HDAC inhibitor for dual-action therapy of breast cancer

Journal:
Chemical Communications
Published:
DOI:
10.1039/d5cc01722j
Affiliations:
2
Authors:
9
Go to article
Institutions Authors Share
MOE Key laboratory of Plant Resource Conservation and Germplasm Innovation in Mountainous Region, GZU, China
7.000000
 0.78
Hubei Normal University (HBNU), China
2.000000
 0.22
Interested in Oncology and Carcinogenesis?